Clinical Trial Update: To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluated the safety and pharmacokinetics of BMS-986177 in healthy Japanese participants; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Drugs mentioned

• BMS-986177

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Thrombosis | Phase 1 | Status: COMPLETED